Reports claiming ALS caused by head trauma lacks scientific validation

November 19, 2010

A recent study (1) suggesting that amyotrophic lateral sclerosis (ALS) may be attributed to "repetitive head trauma experienced in collision sports" lacks scientific epidemiological evidence to support this claim. In a review of the 12-patient study, several experts specializing in motor neuron diseases challenge the findings as entirely pathological and without clinical merit. Their editorial, which aims to dispel doubts of Lou Gehrig's ALS diagnosis, is now available online in the peer-reviewed journal Muscle & Nerve.

ALS, also known as Lou Gehrig's disease, is a progressive neurological disease that attacks nerve cells (neurons) in the brain and spinal cord which control voluntary muscles. As the upper and lower motor neurons degenerate, the muscles they control gradually weaken and waste away, leading to paralysis. Other symptoms of ALS include difficulty breathing, issues with swallowing (gagging, choking), and speech problems. According to the National Institutes of Neurological Disorders and Stroke roughly 20,000 to 30,000 Americans have ALS, and 5,000 patients are diagnosed annually with the disease.

In the editorial, the authors cite two media reports--"Brain Trauma Can Mimic Lou Gehrig's Disease" in the New York Times and "Maybe Lou Gehrig Didn't Die of Lou Gehrig's Disease" in Time magazine--as lacking in scientific validation. These reports have led to numerous inquiries from ALS patients who are seeking answers from their physicians.

"Media coverage generated by the McKee et al. study has caused much concern for our ALS patients who now believe they may be misdiagnosed," said Dr. Stanley H. Appel, Chairman of the Department of Neurology at the Methodist Hospital in Houston, Texas, and one of the foremost experts on Lou Gehrig's disease. "We want to make it clear to physicians and their ALS patients that reports of Lou Gehrig succumbing to anything but the disease which bears his name are inaccurate."

The study in question reported pathological changes of chronic traumatic encephalopathy (CTE) in 12 patients, 3 of whom displayed both the TAR DNA-binding protein (TDP-43) and tau in their spinal cords. The build-up of toxic proteins contributes to a number of neurodegenerative diseases, with TDP-43 found in most ALS cases and tau more commonly associated with dementia. Based on the findings of both proteins in the 3 subjects, the study authors concluded that head trauma and CTE led to an "ALS-like" condition, which one author during media interviews, suggested naming chronic traumatic encephalomyopathy (CTEM).

"There is no clinical or pathological evidence of muscle disease reported in the study that would support a diagnosis of CTEM," added Valerie Cwik, M.D., Executive Vice President and Medical Director for the Muscular Dystrophy Association, and co-author of the editorial. "More likely their 3 patients with CTE and ALS had the two distinct diseases."

The editorial authors maintain that an ALS diagnosis is established when patients meet well-defined clinical criteria rather than identification of pathological findings. Editorial contributor, John W. Day, M.D., Ph.D., Director of the Muscular Dystrophy Clinic at the University of Minnesota Medical Center concluded, "Further studies are needed to fully understand the potential role of trauma in ALS and investigation of TDP-43 and tau as potential targets for therapeutic interventions are warranted."
-end-
1 McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010; 69:918-929.

This editorial is published in Muscle & Nerve. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.

Full citation: "Trauma, TDP-43, and Amyotrophic Lateral Sclerosis." Stanley H. Appel, Valerie A. Cwik and John W. Day. Muscle & Nerve; Published Online: November 19, 2010; (DOI: 10.1002/mus.21939); Print Issue Date: December 2010. Upon publication this link will take you to the editorial: http://doi.wiley.com/10.1002/mus.21939.

Further Reading On Amyotrophic Lateral Sclerosis is Available From Wiley-Blackwell as Free Downloads. Please visit: http://www.wiley.com/WileyCDA/PressRelease/pressReleaseId-86857,descCd-release_additional_material.html.

Muscle & Nerve is an international and interdisciplinary publication of original contributions, in both health and disease, concerning studies of the muscle, the neuromuscular junction, the peripheral motor, sensory and autonomic neurons, and the central nervous system where the behavior of the peripheral nervous system is clarified. Appearing monthly, Muscle & Nerve publishes clinical studies and clinically relevant research reports in the fields of anatomy, biochemistry, cell biology, electrophysiology and electrodiagnosis, epidemiology, genetics, immunology, pathology, pharmacology, physiology, toxicology, and virology. For details on the journal, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4598.

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) was founded in 1953 and is a nonprofit membership association dedicated to the advancement of neuromuscular, musculoskeletal, and electrodiagnostic (EDX) medicine. More than 5000 physician members -- primarily neurologists and physiatrists -- are joined by allied health professionals and PhD Researchers working to improve the quality of medical care to patients with muscle and nerve disorders. For information on AANEM, please visit http://www.aanem.org.

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

Wiley

Related Amyotrophic Lateral Sclerosis Articles from Brightsurf:

Converting lateral scanning into axial focusing to speed up 3D microscopy
In optical microscopy, high-speed volumetric imaging is limited by either the slow axial scanning rate or aberrations introduced by the z-scanning mechanism.

Ammonium triggers formation of lateral roots
Despite the importance of changes in root architecture to exploit local nutrient patches, mechanisms integrating external nutrient signals into the root developmental program remain poorly understood.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Adjustable lordotic expandable vs static lateral lumbar interbody fusion devices
The objective of this study is to compare the clinical and radiographic outcomes between patients treated with static and expandable interbody spacers with adjustable lordosis for MIS LLIF.

Chirality-assisted lateral momentum transfer for bidirectional enantioselective separation
Chiral nanoparticles which twist the light were theoretically predicted to experience lateral forces perpendicular to light vector but lacks experimental verification.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models
Scientists have delayed the onset of amyotrophic lateral sclerosis (ALS) in laboratory models, leaving them cautiously optimistic that the result, combined with other clinical advances, points to a potential treatment for ALS in humans.

Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS).

New clues about the origins of familial forms of Amyotrophic lateral sclerosis
A Brazilian study made important progress in understanding the accumulation of one of the proteins involved in amyotrophic lateral sclerosis (ALS).

Recrutement of a lateral root developmental pathway into root nodule formation of legumes
Peas and other legumes develop spherical or cylindrical structures -- called nodules -- in their roots to establish a mutually beneficial relationship with bacteria that convert atmospheric nitrogen into a useable nutrient for the legume plant.

Read More: Amyotrophic Lateral Sclerosis News and Amyotrophic Lateral Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.